This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pontes-Arruda, A. Articles by Singer, P. Search for Related Content PubMed PubMed Citation Articles by Pontes-Arruda, A. Articles by Singer, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Dietary Fats Social Bookmarking                   What's this?

The Use of an Inflammation-Modulating Diet in Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-Analysis of Outcome Data

From ¹ Intensive Care Department, Fernandes Távora Hospital, Fortaleza, Ceará, Brazil;² Research and Development, Abbott Nutrition, Abbott Laboratories, Columbus, Ohio; ³ Department of General Intensive Care, Rabin Medical Center, Tel Aviv, Israel.

Address correspondence to: Alessandro Pontes-Arruda, MD, MSc, PhD, Intensive Care Department, Fernandes Távora Hospital, Rua Ildefonso Albano 777/403, Fortaleza, Ceará, Brazil 60.115-000; e-mail: pontes-arruda{at}secrel.com.br.

Background: This meta-analysis of clinical trials compares an inflammation-modulating diet enriched with eicosapentaenoic acid (EPA), -linolenic acid (GLA), and elevated antioxidants (EPA + GLA) vs a control diet to determine the effectiveness of this specialized diet on oxygenation and clinical outcomes in mechanically ventilated patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Methods: MEDLINE, EMBASE, Cochrane Clinical Trials Register, and the U.S. National Institute of Health Clinical Trials databases were searched. The outcome measures assessed were 28-day in-hospital mortality, 28-day ventilator-free and intensive care unit (ICU)-free days, and the development of new organ failures. An evaluation of oxygenation and ventilatory variables was also performed. Outcomes were analyzed using both fixed-effects and random-effects models. Results: Three randomized controlled studies (n = 411 patients) were included in this meta-analysis. Among the most important findings of this evaluation is a significant reduction in the risk of mortality (odds ratio [OR] = 0.40; 95% confidence interval [CI] = 0.24–0.68; P = .001), with significant reductions in the risk of developing new organ failures (OR = 0.17; 95% CI = 0.08–0.34; P < .0001), time on mechanical ventilation (standardized mean difference [SMD] = 0.56; 95% CI = 0.32–0.79; P < .0001), and ICU stay (SMD = 0.51; 95% CI = 0.27–0.74; P < .0001) in patients who received EPA + GLA. Conclusions: The meta-analysis showed a significant reduction in the risk of mortality as well as relevant improvements in oxygenation and clinical outcomes of ventilated patients with ALI/ARDS given EPA + GLA.

Key Words: meta-analysis • eicosapentaenoic acid • -linolenic acid • ARDS • ALI • sepsis • inflammation • borage oil • fish oil • critical care • omega-3 fatty acids

Journal of Parenteral and Enteral Nutrition, Vol. 32, No. 6, 596-605 (2008)
DOI: 10.1177/0148607108324203


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?